136 related articles for article (PubMed ID: 30230033)
1. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
Chen JC; Huang C; Lee IN; Wu YP; Tang CH
Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
[TBL] [Abstract][Full Text] [Related]
2. Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression.
Hsieh MJ; Huang C; Lin CC; Tang CH; Lin CY; Lee IN; Huang HC; Chen JC
Mol Carcinog; 2020 Mar; 59(3):293-303. PubMed ID: 31916307
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin Promotes Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis through STAT3 Activation in Human Chondrosarcoma Cells.
Huang YW; Tsai HC; Wang SW; Kuo SJ; Fong YC; Tang CH
Cell Physiol Biochem; 2019; 52(1):1-15. PubMed ID: 30790501
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin.
Chen JC; Shih HC; Lin CY; Guo JH; Huang C; Huang HC; Chong ZY; Tang CH
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614283
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.
Chen JC; Chen YJ; Lin CY; Fong YC; Hsu CJ; Tsai CH; Su JL; Tang CH
Oncotarget; 2015 May; 6(13):11434-46. PubMed ID: 25825984
[TBL] [Abstract][Full Text] [Related]
6. Effects of ethanol on the anticancer function of doxorubicin in JJ012 cells.
Huang H; Li Y; Wu M; Luo J; Nie J; Hou B; He Q; Diao Y; Qi L; Zhao Y; Liu Y; Yang D; Zhou L
Future Oncol; 2018 Jun; 14(13):1285-1297. PubMed ID: 29774752
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 enhances cell migration through COX-2 up-regulation in human chondrosarcoma.
Wu MH; Chen LM; Hsu HH; Lin JA; Lin YM; Tsai FJ; Tsai CH; Huang CY; Tang CH
Biochim Biophys Acta; 2013 Jun; 1830(6):3355-64. PubMed ID: 23523690
[TBL] [Abstract][Full Text] [Related]
8. Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.
Wu YY; Law YY; Huang YW; Tran NB; Lin CY; Lai CY; Huang YL; Tsai CH; Ko CY; Chou MC; Huang WC; Cheng FJ; Fong YC; Tang CH
Int J Biol Sci; 2023; 19(16):5174-5186. PubMed ID: 37928274
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.
Wang CQ; Huang YW; Wang SW; Huang YL; Tsai CH; Zhao YM; Huang BF; Xu GH; Fong YC; Tang CH
Cancer Lett; 2017 Jan; 385():261-270. PubMed ID: 27826039
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of CSPG4/NG2 in chondrosarcoma.
Jamil NS; Azfer A; Worrell H; Salter DM
Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
[TBL] [Abstract][Full Text] [Related]
11. CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Tan TW; Lai CH; Huang CY; Yang WH; Chen HT; Hsu HC; Fong YC; Tang CH
J Cell Biochem; 2009 May; 107(2):345-56. PubMed ID: 19301259
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression.
Higuchi T; Takeuchi A; Munesue S; Yamamoto N; Hayashi K; Kimura H; Miwa S; Inatani H; Shimozaki S; Kato T; Aoki Y; Abe K; Taniguchi Y; Aiba H; Murakami H; Harashima A; Yamamoto Y; Tsuchiya H
Cancer Med; 2018 May; 7(5):1944-1954. PubMed ID: 29573200
[TBL] [Abstract][Full Text] [Related]
13. Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A.
Hua G; Liu Y; Li X; Xu P; Luo Y
Oncol Rep; 2014 Jun; 31(6):2727-34. PubMed ID: 24789077
[TBL] [Abstract][Full Text] [Related]
14. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
[TBL] [Abstract][Full Text] [Related]
15. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin promotes cisplatin chemoresistance by upregulating ABCB1 expression in human chondrosarcoma.
Huang YW; Lin CY; Tsai HC; Fong YC; Han CK; Huang YL; Wu WT; Cheng SP; Chang HC; Liao KW; Wang SW; Tang CH
Aging (Albany NY); 2020 May; 12(10):9475-9488. PubMed ID: 32428872
[TBL] [Abstract][Full Text] [Related]
17. Secreted amphiregulin promotes vincristine resistance in oral squamous cell carcinoma.
Hsieh MJ; Chen YH; Lee IN; Huang C; Ku YJ; Chen JC
Int J Oncol; 2019 Oct; 55(4):949-959. PubMed ID: 31485602
[TBL] [Abstract][Full Text] [Related]
18. No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.
Peterse EF; Cleven AH; De Jong Y; Briaire-de Bruijn I; Fletcher JA; Danen EH; Cleton-Jansen AM; Bovée JV
BMC Cancer; 2016 Jul; 16():475. PubMed ID: 27418340
[TBL] [Abstract][Full Text] [Related]
19. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
[TBL] [Abstract][Full Text] [Related]
20. CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.
Tzeng HE; Tang CH; Wu SH; Chen HT; Fong YC; Lu YC; Chen WC; Huang HD; Lin CY; Wang SW
Cell Death Dis; 2018 Sep; 9(10):955. PubMed ID: 30237403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
